The risk of myocardial infarction, stroke, and revascularization among patients with psoriasis treated with apremilast compared with biologics and disease-modifying antirheumatic drugs: A cohort study in the US MarketScan database - 19/06/20
Doi : 10.1016/j.jaad.2020.03.043
Rebecca Persson, MPH a, Katrina Wilcox Hagberg, MPH a, Yiran Qian, MD, MPH a, Catherine Vasilakis-Scaramozza, PhD a, Susan Jick, ScD a, b, ⁎ 
a Boston Collaborative Drug Surveillance Program, Lexington, Massachusetts
b Boston University School of Public Health, Boston, Massachusetts
∗Correspondence to: Susan Jick, ScD
| Funding sources: Supported by Celgene Corporation (Summit, NJ). |
|
| Conflicts of interest: Drs Vasilakis-Scaramozza and Jick, Ms Persson, and Ms Hagberg are employees of Boston Collaborative Drug Surveillance Program (BCDSP). Dr Qian is a former employee of BCDSP. BCDSP received a grant from Celgene Corporation to fund this project. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 1
P. 271-274 - juillet 2020 Retour au numéro
Article précédent
- Dermoscopic predictors to discriminate between in situ and early invasive lentigo maligna melanoma: A retrospective observational study
- Leonardo Peruilh-Bagolini, Zoe Apalla, Ruben González-Cuevas, Konstantinos Lallas, Chryssoula Papageorgiou, Mattheos Bobos, Sofia Magdalini Manoli, Theodosia Gkentsidi, Ioannis Spyridis, Elizabeth Lazaridou, Elena Sotiriou, Efstratios Vakirlis, Dimitrios Ioannides, Aimilios Lallas
- Factors associated with surgical site infection of the lower extremity: A retrospective cohort study
- Neera R. Nathan, Daniel M. O'Connor, Jeffrey B. Tiger, Laura M. Sowerby, Suzanne M. Olbricht, Su Luo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?